Prot# PN400-307: Randomized, Double-Blind, Parallel Group, Placebo-Controlled Multi-Center Study Evaluating the Efficacy of PN 400 BID and Celecoxib 200 mg QD in Patients with Osteoarthritis of the Knee.

Project: Research project

Project Details

StatusFinished
Effective start/end date7/17/087/17/11

Funding

  • Kendle International Inc. (PN400-307)
  • POZEN Inc. (PN400-307)